Diet and Supplement Strategy

Treatment Hierarchy

flowchart TD
    subgraph T1["Tier 1 - Foundation"]
        P[Phlebotomy] --> R1[Reduce Iron Load]
        DI[Iron-Reducing Diet] --> R1
    end

    subgraph T2["Tier 2 - Core Supplements"]
        NAC[NAC 1200-2400mg] --> R2[Antioxidant + TTM]
        VD[Vitamin D3 + K2] --> R3[Immune + Hepcidin]
        PRO[Probiotics] --> R4[Gut Recolonisation]
    end

    subgraph T3["Tier 3 - Targeted Support"]
        INO[Inositol] --> R5[TTM Adjunct]
        MF[Methylfolate] --> R6[MTHFR Support]
        MIN[Zn + Mg Optimisation] --> R7[Enzyme Cofactors]
    end

    R1 -.-> R4
    R1 -.-> MIN

    MON[Quarterly Bloods] -.-> P
    MON -.-> NAC
    MON -.-> VD

    classDef tier1 fill:#f0b27a,stroke:#ca6f1e,color:#1a1000
    classDef tier2 fill:#85c1e9,stroke:#2471a3,color:#0a1929
    classDef tier3 fill:#58d68d,stroke:#1e8449,color:#0a1f12
    classDef monitor fill:#d5dbdb,stroke:#7f8c8d,color:#1a1a1a

    class P,DI,R1 tier1
    class NAC,VD,PRO,R2,R3,R4 tier2
    class INO,MF,MIN,R5,R6,R7 tier3
    class MON monitor

Current Supplement Stack — Review

What Anthony Currently Takes

Stack Assessment

The current stack is reasonable and well-constructed. No harmful interactions identified. Key gaps are identified below.

Recommended Additions

1. NAC (N-Acetylcysteine) — HIGH PRIORITY

Why: Multi-target molecule addressing three of Anthony's core issues simultaneously.

Dose: 1200mg–2400mg/day, split into two doses
Onset: 4–9 weeks for TTM benefit
Timing: Can be taken with or without food; separate from Elvanse by ~1 hour (good practice, no known interaction)
Safety: Generally well-tolerated; mild GI effects possible; may increase the effect of some medications on blood pressure. Safe in iron-loaded patients — see NAC and Iron Metabolism for full evidence review including thalassemia RCT safety data.
Note: NAC is also a mucolytic — may cause mild increase in mucus clearance initially

Buying Guide (UK)

Standard NAC (N-acetyl-L-cysteine) capsules are sufficient — no need for "sustained release" or premium formulations. The Grant 2009 TTM trial used plain NAC capsules. Choose 600mg capsules for easy dose titration.

Starting protocol: 600mg morning + 600mg evening (1200mg/day) for 2 weeks, then increase to 1200mg morning + 1200mg evening (2400mg/day) if tolerated. Monitor at next quarterly bloods — not for NAC-specific concerns but as standard HFE practice.

2. Vitamin D3 — HIGH PRIORITY

Why: Untested in Anthony's blood work, and has strong associations with all his conditions.

Action: Test 25-OH vitamin D first — then supplement based on results
Typical dose if deficient: 2000–4000 IU/day for maintenance; higher loading dose if severely deficient
Cofactors: Vitamin K2 (MK-7) should accompany high-dose D3 to direct calcium to bones

3. Probiotics — MODERATE PRIORITY

Why: Iron overload suppresses beneficial gut bacteria (especially Lactobacilli); probiotics may help recolonise.

Recommended strains:

• Lactobacillus rhamnosus GG — gut barrier support, GABA modulation
• Bifidobacterium longum — stress resilience, cortisol reduction
• Lactobacillus plantarum 299v — may modulate kynurenine pathway

Timing: Consider starting after phlebotomy begins (reducing iron load first improves gut environment for colonisation)
Note: Lactobacilli don't require iron for growth → may thrive even in current iron-loaded gut

4. Inositol — MODERATE PRIORITY (for TTM)

Why: Targets serotonergic signalling via phosphoinositide pathway — different mechanism than NAC.

Evidence: As effective as SSRIs for OCD in small studies; anecdotal evidence in TTM at 18g/day
Dose: Start at 2g/day, titrate up to 12–18g/day for TTM
Consideration: High doses needed for effect; may cause GI upset initially
Strategy: Try NAC first (better evidence for TTM specifically); add inositol if NAC alone is insufficient

Supplement Timing Optimisation

Key timing rules:

• Zinc away from meals containing iron, calcium, or phytates
• NAC can be taken with or without food
• Magnesium at bedtime may improve sleep quality
• Fish oil with food for absorption

Dietary Considerations

Iron-Reducing Diet (Continue)

See Dietary Management - Iron Overload for full detail. Key principles:

• Tea/coffee with meals (tannins inhibit iron absorption)
• Calcium-rich foods at meals (dairy, fortified alternatives)
• Minimise red meat; prefer poultry, fish, legumes, eggs
• No vitamin C supplements; avoid large citrus at meals
• No raw shellfish (Vibrio risk)
• Check cereals for iron fortification
• Avoid cast iron cookware for acidic dishes

AuDHD-Specific Dietary Considerations

Protein Adequacy

• Elvanse appetite suppression can reduce overall intake
• Protein is essential for neurotransmitter precursors (tyrosine → dopamine; tryptophan → serotonin)
• Ensure adequate protein intake despite appetite suppression
• Bovine collagen contributes to amino acid intake (glycine, proline) but is not a complete protein

Omega-3 Optimisation

• Current fish oil (high DPA/DHA) is good
• Ensure EPA component is adequate — EPA may be more relevant for ADHD than DHA
• Target: ≥750mg combined EPA+DHA daily
• Higher EPA doses (1200mg/day) if inflammatory markers are elevated

Fibre for Gut Health

• Increased fibre → increased SCFA production → better gut barrier → reduced inflammation
• Prebiotic fibres (inulin, FOS) feed beneficial bacteria
• Particularly important given iron overload's effect on gut microbiome

Meal Timing with Elvanse

• Appetite suppression typically strongest 2–6 hours post-dose
• Front-load protein at breakfast (before Elvanse kicks in)
• Use calorie-dense snacks when appetite is low
• Don't skip meals even when not hungry

What NOT to Add

Treatment Hierarchy — Priority Order

Based on evidence strength, multi-target potential, and clinical urgency:

1. Phlebotomy — addresses iron overload, reduces oxidative stress, improves mineral balance, may improve gut microbiome, reduce neuroinflammation (see Action Items and Monitoring Plan)
2. Vitamin D testing and supplementation — simple, high-impact if deficient, addresses TTM (OR 4.2), ADHD, and autism associations
3. NAC 1200–2400mg/day — multi-target for TTM, oxidative stress, glutamate, neuroinflammation
4. Switch to methylfolate NOW — Dec 2025 bloods confirm folate 6.8 nmol/L (LOW) despite folic acid supplementation → strong MTHFR suspicion; switch to methylfolate 5-MTHF 400–800 µg/day immediately; get MTHFR tested
5. Continue current stack — Mg, Zn, creatine, fish oil, collagen all have supporting evidence
6. Probiotics — after phlebotomy begins, to support gut recolonisation
7. Inositol — if NAC alone insufficient for TTM after 8–12 weeks
8. Comprehensive stool analysis — to assess gut microbiome status

Monitoring Schedule

Verified Academic Citations

Citations verified via PubMed and OpenAlex on 2026-03-22. Organised by supplement/intervention.

NAC (N-Acetylcysteine)

1. Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756-763. PMID: 19581567 | DOI: 10.1001/archgenpsychiatry.2009.60

   • 12-week RCT, n=50. 56% response rate on NAC 1200-2400 mg/d vs 16% placebo (P=.003). First RCT of a glutamatergic agent for TTM.

2. Hoffman J, Williams T, Rothbart R, et al. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev. 2021;9:CD007662. PMID: 34582562 | DOI: 10.1002/14651858.CD007662.pub3

   • Cochrane systematic review. Identified NAC as having the strongest RCT evidence among pharmacotherapies for TTM.

3. Deepmala, Slattery J, Kumar N, et al. Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review. Neurosci Biobehav Rev. 2015;55:294-321. PMID: 25957927 | DOI: 10.1016/j.neubiorev.2015.04.015

   • Systematic review of NAC across psychiatric conditions including TTM, OCD, autism, and substance use disorders.

4. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11(6):851-876. DOI: 10.1017/S1461145707008401 | OpenAlex: W1986211748 (1,069 citations)

   • Review establishing NAC as glutathione precursor with antioxidant and glutamate-modulating properties relevant to psychiatric disorders.

Vitamin D

5. Akaltun I. Trichotillomania triggered by vitamin D deficiency and resolving dramatically with vitamin D therapy. Clin Neuropharmacol. 2019;42(2):68-69. PMID: 30649027 | DOI: 10.1097/WNF.0000000000000317

   • Case report: TTM resolved with vitamin D supplementation in a deficient patient.

6. Titus-Lay E, Eid TJ, Kreys TJ, et al. Trichotillomania associated with a 25-hydroxy vitamin D deficiency: a case report. Ment Health Clin. 2020;10(1):44-47. PMID: 31942278 | DOI: 10.9740/mhc.2020.01.038

   • Case report documenting TTM improvement following vitamin D repletion.

7. Zhang M, Wu Y, Lu Z, et al. Effects of vitamin D supplementation on children with autism spectrum disorder: a systematic review and meta-analysis. Clin Psychopharmacol Neurosci. 2023;21(2):240-251. PMID: 37119216 | DOI: 10.9758/cpn.2023.21.2.240

   • Meta-analysis finding vitamin D supplementation significantly improved ASD symptom severity scores.

8. Shen Y, Xie Y, Zheng Y, et al. Vitamin interventions in ASD and ADHD: systematic review and meta-analysis. Neuropsychiatr Dis Treat. 2025;21:1229-1248. PMID: 40910091 | DOI: 10.2147/NDT.S553063

   • 2025 meta-analysis covering vitamin D and other vitamin interventions in both ASD and ADHD.

Omega-3 Fatty Acids

9. Liu TH, Wu JY, Huang PY, et al. Omega-3 polyunsaturated fatty acids for core symptoms of attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials. J Clin Psychiatry. 2023;84(5):22r14772. PMID: 37656283 | DOI: 10.4088/JCP.22r14772
   • Meta-analysis of RCTs finding omega-3 PUFAs significantly improved ADHD core symptoms (inattention and hyperactivity).

Magnesium

10. Hemamy M, Pahlavani N, Amanollahi A, et al. The effect of vitamin D and magnesium supplementation on the mental health status of attention-deficit hyperactive children: a randomized controlled trial. BMC Pediatr. 2021;21:178. PMID: 33865361 | DOI: 10.1186/s12887-021-02631-1
    • RCT showing combined vitamin D + magnesium supplementation improved emotional problems, conduct problems, and peer problems in ADHD children.

Creatine

11. Xu C, Bi S, Zhang W, et al. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Front Nutr. 2024;11:1424972. PMID: 39070254 | DOI: 10.3389/fnut.2024.1424972

    • 2024 meta-analysis demonstrating creatine supplementation improves cognitive function in adults, particularly short-term memory and reasoning.

12. Prokopidis K, Giannos P, Triantafyllidis KK, et al. Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2023;81(4):416-427. PMID: 35984306 | DOI: 10.1093/nutrit/nuac064

    • Meta-analysis of RCTs finding creatine improved memory performance, with greater effects in older adults and under stress conditions.

Zinc

13. Talebi S, Miraghajani M, Ghavami A, et al. The effect of zinc supplementation in children with attention deficit hyperactivity disorder: a systematic review and dose-response meta-analysis of randomized clinical trials. Crit Rev Food Sci Nutr. 2022;62(32):9093-9102. PMID: 34184967 | DOI: 10.1080/10408398.2021.1940833
    • Dose-response meta-analysis showing zinc supplementation reduced hyperactivity in ADHD children in a dose-dependent manner.

Iron and ADHD

14. Konofal E, Lecendreux M, Deron J, et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol. 2008;38(1):20-26. PMID: 18054688 | DOI: 10.1016/j.pediatrneurol.2007.08.014

    • RCT showing iron supplementation (80 mg/d ferrous sulfate) improved ADHD symptoms in iron-deficient (non-anaemic) children over 12 weeks.

15. Granero R, Pardo-Garrido A, Carpio-Toro IL, et al. The role of iron and zinc in the treatment of ADHD among children and adolescents: a systematic review of randomized clinical trials. Nutrients. 2021;13(11):4059. PMID: 34836314 | DOI: 10.3390/nu13114059

    • Systematic review of iron and zinc RCTs for ADHD. Supports supplementation when deficient; not applicable to iron-overloaded patients.

16. Fiani D, Chahine S, Zaboube M, et al. Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: a meta-analysis and systematic review. Neurosci Biobehav Rev. 2025;178:106372. PMID: 40945632 | DOI: 10.1016/j.neubiorev.2025.106372

    • 2025 meta-analysis (18 studies, n=1408). Iron supplementation improved anxiety, fatigue, cognition, and short-term memory in non-anaemic iron-deficient individuals. Note: Anthony has iron overload — iron supplementation is contraindicated; included for mechanistic understanding of iron-brain link only.

Folate / MTHFR

17. Wan L, Li Y, Zhang Z, et al. Methylenetetrahydrofolate reductase and psychiatric diseases. Transl Psychiatry. 2018;8:242. PMID: 30397195 | DOI: 10.1038/s41398-018-0276-6

    • Review of MTHFR polymorphisms across psychiatric disorders (schizophrenia, depression, autism, bipolar). Reduced MTHFR activity impairs DNA methylation and may benefit from folate supplementation.

18. Saha T, Chatterjee M, Verma D, et al. Genetic variants of the folate metabolic system and mild hyperhomocysteinemia may affect ADHD associated behavioral problems. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84(Pt A):1-10. PMID: 29407547 | DOI: 10.1016/j.pnpbp.2018.01.016

    • Found MTHFR and related folate-pathway variants significantly associated with ADHD behavioural traits and hyperhomocysteinaemia.

Antioxidant Network Meta-analysis (Vitamin D, Omega-3, Zinc, NAC)

19. Zhou P, Yu X, Song T, et al. Safety and efficacy of antioxidant therapy in children and adolescents with attention deficit hyperactivity disorder: a systematic review and network meta-analysis. PLoS One. 2024;19(3):e0296926. PMID: 38547138 | DOI: 10.1371/journal.pone.0296926
    • Network meta-analysis comparing vitamin D, omega-3, zinc, and other antioxidants for ADHD. Found vitamin D and omega-3 among the most effective antioxidant interventions.

Probiotics and Gut-Brain Axis

20. Novau-Ferré N, Papandreou C, Rojo-Marticella M, et al. Gut microbiome differences in children with ADHD and ASD and effects of probiotic supplementation: a randomized controlled trial. Res Dev Disabil. 2025;150:105003. PMID: 40184961 | DOI: 10.1016/j.ridd.2025.105003
    • 2025 RCT demonstrating gut microbiome alterations in ADHD/ASD children and partial normalisation with probiotic supplementation.

Inositol

21. Sarris J, Camfield D, Berk M. Complementary medicine, self-help, and lifestyle interventions for obsessive compulsive disorder (OCD) and the OCD spectrum: a systematic review. J Affect Disord. 2012;138(3):213-221. PMID: 21620478 | DOI: 10.1016/j.jad.2011.04.051
    • Systematic review covering inositol for OCD-spectrum disorders including TTM. Found preliminary evidence for inositol at 18 g/day, comparable to SSRIs in small trials.

Phlebotomy and Hemochromatosis Cognition

22. Brown S, Torrens LA. Ironing out the rough spots — cognitive impairment in haemochromatosis. BMJ Case Rep. 2012;2012:bcr0320126147. PMID: 22761228 | DOI: 10.1136/bcr.03.2012.6147

    • Case report documenting cognitive impairment in hemochromatosis, with relevance to Anthony's HFE compound heterozygosity.

23. Dwyer BE, Zacharski LR, Balestra DJ, et al. Getting the iron out: phlebotomy for Alzheimer's disease? Med Hypotheses. 2009;72(5):504-509. PMID: 19195795 | DOI: 10.1016/j.mehy.2008.12.029

    • Hypothesis paper proposing therapeutic phlebotomy to reduce brain iron load and oxidative stress in neurodegeneration.

Cross-References

• Dietary Management - Iron Overload
• Action Items and Monitoring Plan
• Trichotillomania and Neurodevelopmental Links
• Tryptophan-Kynurenine Pathway
• Gut-Brain Axis and Neurodevelopment
• Copper-Zinc-Iron Interactions
• Iron Overload and NTBI
• Elvanse and Mineral Metabolism
• Genetic Architecture of AuDHD
• Late-Diagnosed Autism - Distinct Profile